Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.07 -0.07 (-0.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Net Equity Issued and Repurchased (2018 - 2026)

Updated

Amneal Pharmaceuticals' Net Equity Issued and Repurchased came in at $42,000 for Q2 2026, down 93.9% from $685,000 a year earlier but up 10.5% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Amneal Pharmaceuticals reported Net Equity Issued and Repurchased of $1.29 million, down 15.5% year-over-year; for FY2025, it came in at $1.96 million, up 69.8% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 43.6% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $1.15 million in FY2024 (+155.9%), $451,000 in FY2023 (-31.9%), $662,000 in FY2022 (-22.4%) and $853,000 in FY2021 (+165.7%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is $19,000 (Q4 2021) to $685,000 (Q2 2025).
  • Year-over-year, Net Equity Issued and Repurchased increased in six of the last eight quarters, with growth averaging 84.2%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q4 2025 (growth of 266.2%), and the weakest in Q2 2026 (a decline of 93.9%).
  • Business Quant data shows AMRX's Net Equity Issued and Repurchased at $38,000 (Q1 2026), $553,000 (Q4 2025) and $653,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Amneal Pharmaceuticals 6.43 Bn 5.71 Bn 334.51 Mn 42,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42,000.00
Mar 31, 2026 38,000.00
Dec 31, 2025 553,000.00
Sep 30, 2025 653,000.00
Jun 30, 2025 685,000.00
Mar 31, 2025 69,000.00
Dec 31, 2024 151,000.00
Sep 30, 2024 617,000.00
Jun 30, 2024 358,000.00
Mar 31, 2024 28,000.00
Dec 31, 2023 43,000.00
Sep 30, 2023 408,000.00
Sep 30, 2022 423,000.00
Jun 30, 2022 128,000.00
Mar 31, 2022 111,000.00
Dec 31, 2021 19,000.00
Sep 30, 2021 153,000.00
Jun 30, 2021 5,000.00
Mar 31, 2021 676,000.00
Dec 31, 2020 105,000.00
API Access

Amneal Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AMRX&period=max&api_key=YOUR_API_KEY